NVAXNovavax, Inc.

$10.19

What is the market doing?

What the tape says about NVAX

Novavax, Inc. is +4.9% over the past year while the S&P 500 is +20%: 15 points behind the market.

+4.9%

1-year return · S&P 500 +20%

vs 200-day average
+20%

vs 200-day average · a clear uptrend

RSI (14)
76

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
8.9%

Below its 52-week high

2024-08-15$5.43 – $14.68 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$10.19
1 monthS&P 500 −0.30%
+32%
1 yearS&P 500 +20%
+4.9%
5 yearsS&P 500 +85%
−96%
vs 50-day average$8.62
+18%
52-week high
$11.19
52-week low
$6.22
Annualised volatility
75%
Calendar-year price return
YearReturn
2026 (year to date)+52%
2025−16%
2024+67%
2023−53%
2022−93%
2021+28%
2020+2702%
2019−89%
2018+48%
2017−1.6%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan108 of 10+28%
Feb106 of 10+7.5%
Mar100 of 10−16%
Apr104 of 10−3.7%
May108 of 10+41%
Jun104 of 10+6.9%
Jul116 of 11+3.6%
Aug116 of 11+4.4%
Sep115 of 11−9.0%
Oct101 of 10−12%
Nov105 of 10+8.3%
Dec101 of 10−15%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.